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Chronic gastritis is characterized by gastric mucosal inflammation due to autoimmune
responses or infection, frequently with Helicobacter pylori. Gastritis with H. pylori back-
ground can cause gastric mucosa-associated lymphoid tissue lymphoma (MALT-L), which
sometimes further transforms into diffuse large B-cell lymphoma (DLBCL). However, gas-
tric DLBCL can also be initiated de novo. The mechanisms underlying transformation into
DLBCL are not completely understood.We analyzed immunoglobulin repertoires and clonal
trees to investigate whether and how immunoglobulin gene repertoires, clonal diversifica-
tion, and selection in gastritis, gastric MALT-L, and DLBCL differ from each other and from
normal responses. The two gastritis types (positive or negative for H. pylori ) had similarly
diverse repertoires. MALT-L dominant clones (defined as the largest clones in each sample)
presented higher diversification and longer mutational histories compared with all other
conditions. DLBCL dominant clones displayed lower clonal diversification, suggesting the
transforming events are triggered by similar responses in different patients. These results
are surprising, as we expected to find similarities between the dominant clones of gastritis
and MALT-L and between those of MALT-L and DLBCL.
Keywords: B-cells, gastritis, H. pylori, MALT lymphoma, DLBCL, Ig gene, repertoire, somatic hypermutation
INTRODUCTION
Chronic gastritis is a common disorder characterized by chronic
inflammation of gastric mucosa. In acute gastritis, patients suffer
from dyspeptic symptoms including epigastric burning, distention
or bloating, belching, episodic nausea, flatulence, and halitosis. In
contrast, most patients with chronic gastritis are asymptomatic
(1). One of the major causes of gastritis is bacterial infection,
most frequently with Helicobacter pylori (H. pylori). H. pylori are
Gram-negative bacteria that are present in the gastric mucosa
of more than 50% of people and may persist lifelong unless
treated (2). H. pylori are resistant to elimination by the immune
response so the immune system fails to remove the infection
effectively (3). Previous studies have shown a strong association
between gastritis and H. pylori infection, at least in the early
stages of gastritis (3, 4). Although rare, organisms other than
H. pylori (e.g., Mycobacterium avium-intracellulare, Herpes sim-
plex, Cytomegalovirus, and Epstein–Barr virus) can invade the
Abbreviations: AML, acute myeloid leukemia; B-CLL, chronic lymphocytic
leukemia; BCR, B-cell receptor; CDR, complementary determining region; CI, con-
fidence intervals; CLN, control lymph node; DLBCL, diffuse large B-cell lymphoma;
FL, follicular lymphoma; GHP, gastritis with H. pylori background; GNHP, gastritis
without H. pylori background; H. pylori, Helicobacter pylori; HTS, high-throughput
sequencing; Indels, insertions and/or deletions; MALT, mucosa-associated lymphoid
tissue; MALT-L, MALT lymphoma; MID, molecular identification; MM, multiple
myeloma; SHM, somatic hypermutation.
gastric mucosa and cause inflammation (5, 6). Gastritis can also
be initiated de novo, as an autoimmune disease (7). In either case,
prolonged antigenic stimulation causing chronic inflammation
might further contribute to the development of some malignancies
(8), such as gastric mucosa-associated lymphoid tissue (MALT)
lymphoma (9–16).
Mucosa-associated lymphoid tissue lymphoma (MALT-L) is a
low-grade B-cell lymphoma. It grows slowly and remains confined
to one organ for a relatively long time. Stomach MALT-L exempli-
fies the close link between chronic inflammation and lymphoma-
genesis. B-cells of MALT-L are related to normal marginal zone
cells. Their IgH variable region gene sequences exhibit features
of post germinal center B-cells, such as somatic hypermutation
(SHM), implying that the clone has expanded in the presence of an
antigen (17). MALT-L is often associated with bacterial infection,
most commonly by H. pylori bacterium (7–9, 15–17).
A possible outcome of low-grade B-cell lymphomas such as
MALT-L is the transformation into a more aggressive lymphoma
such as diffuse large B-cell lymphoma (DLBCL) (18, 19). Gastric
DLBCL is a fast-growing, aggressive B-cell malignancy character-
ized by diffuse proliferation of large neoplastic lymphoid B-cells
(20, 21). DLBCL is known to represent a heterogeneous group of
malignancies, comprising either germinal center-like cells exhibit-
ing intra-clonal diversity or “activated B-cell-like” cells, which do
not (22, 23).
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During the clonal expansion of B-cells in response to an anti-
gen, Ig gene sequences from clonally related B-cells (i.e., B-cells
that are derivatives of the same B-cell ancestor) accumulate muta-
tions via SHM and thus diversify. Clonally related cells are iden-
tified by identical V(D)J segments and by highly homologous
sequences of the complementary determining region (CDR) 3 of
their Ig genes. An easy way to track and analyze the relationships
between clonally related Ig gene sequences is by using lineage trees.
The tree root is the ancestor sequence, usually the rearranged,
pre-mutation sequence. Each tree node represents a single muta-
tion (point mutation, insertion, or deletion). Lineage trees have
been used in order to quantify the differences between the dynam-
ics of SHM and antigen-driven selection in different lymphoid
tissues, species, and disease situations. Our lineage trees-based
mutation analysis has demonstrated its usefulness in previous
studies of aging (24), autoimmunity (25–28), and chronic inflam-
mation (29). Recent work on B-cell malignancies done in our
lab (30–32) showed differences in tree properties between lym-
phomas and controls. Lymphoma trees were more branched and
had longer trunks compared to controls, indicating a higher intra-
clonal diversification and a longer mutational history. Intra-clonal
diversification was also shown in chronic lymphocytic leukemia
cases (33–35), in marginal zone lymphoma cases (36, 37) and in
intestinal DLBCL cases (21). In addition, lymphoma and controls
exhibited similar mutation rates and same SHM motifs. Follicular
lymphoma (FL), which is considered a less aggressive lymphoma,
displayed higher diversity than DLBCL and highest recent diver-
sification events, suggesting that the more aggressive lymphoma
diversifies the least (38–40).
In the present study, we used repertoire, lineage tree, and muta-
tion analyses to investigate whether and how B-cell repertoires,
clonal diversification, and selection mechanisms in gastritis, gas-
tric MALT-L, and DLBCL differ from each other and from normal
responses. The two types of gastritis (positive or negative for H.
pylori) were found to have similar repertoires and diversification.
MALT-L clones were found to be more diversified and had longer
mutational histories compared with all other conditions, but the
dominant clones of MALT-L (defined as the largest clones in each
sample) were different from those of all other conditions. DLBCL
dominant clones, however, displayed lower diversification. These
results are surprising, as we expected to find similarities between
the dominant clones of gastritis and MALT-L and between those
of MALT-L and DLBCL, according to the hypothesis that these are
often sequential steps of inflammation and transformation.
RESULTS
REPERTOIRES IN GASTRITIS WITH H. PYLORI BACKGROUNDWERE AS
DIVERSE AS THOSE IN GASTRITIS NEGATIVE FOR H. PYLORI, AND
CONTAINED SIMILAR V(D)J COMBINATIONS
We compared the repertoires in both types of gastritis, with
H. pylori background (GHP) or without H. pylori background
(GNHP), and examined the differences between them. We
expected the repertoire in GHP to be less diverse due to the
response to the bacterium, as previous studies showed that mono-
clonality is frequently found in GHP samples [(41–43) and others].
In contrast to our expectation, the confidence intervals (CI) of
alpha, beta, and gamma diversity indices of both orders were
FIGURE 1 | Graphic presentation of alpha, beta, and gamma diversity
indices of order 1 and 2. Diversity measures were calculated, as
described in the Section “Materials and Methods,” based on the Shannon
entropy and the Simpson concentration diversity indices. The alpha diversity
measure represents the average sample diversity in each
condition/population.The gamma diversity measure represents the “global”
repertoire diversity across all samples studied in each condition/population.
The beta diversity measure represents the diversity component resulting
from the variability between samples. In our Ig gene repertoire studies, the
abundance data (numbers of unique sequences) of antibody clones in each
sample was used to estimate the mean, standard error, and 95%
confidence intervals (CI) of the total number of unique sequences in clones
within each sample. The CI allows us to compare between diversity indices
of different conditions. The error bars show the standard errors.
overlapping (Figure 1), implying the average individual biopsy
diversities, the variability of diversities between individual biop-
sies, and the overall pool diversities in GHP and GNHP were not
statistically different. Indeed, most V(D)J combinations observed
were expressed in both gastritis types (Figures 2A,B).
Gastritis with H. pylori background and GNHP were the most
similar conditions (similarity index of 0.543, Table 1), although
one GHP sample (the second GHP sample in Table S1 in Sup-
plementary Material) had an extremely high alpha diversity index
compared to the other two samples (data not shown). This con-
tradicts our expectation of narrower repertoires in GHP samples
due to the presence of H. pylori. However, if the one highly diverse
GHP sample is excluded from the analysis, the confidence interval
of alpha of GHP becomes narrower (3.9–11.25), and lower than
that of GNHP. It is possible that the highly diverse sample reflected
additional ongoing responses.
VH1-3/JH4 was a common combination in both GNHP and
GHP VH–JH repertoires, but not so prominent in repertoires of
other conditions (Figures 2A,B). These combinations contained
several DH genes in both GNHP and GHP. However, identification
of D genes should be taken with caution, as SoDA always finds a D
gene, even when this is based on too-few nucleotides to be reliable.
Table 2 summarizes all common combinations and genes found
in our study and their relationships with other clinical conditions
as implicated in the literature.
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FIGURE 2 | Average percentages of clones in each VH–JH combination, in (A) GHP, (B) GNHP, and (C) CLN samples.
Table 1 |The average similarity between each pair of conditions.
CLN GNHP GHP
CLN 0.211 0.295 0.343
GNHP 0.408 0.543
GHP 0.478
Similarity measures were calculated between all clones in all samples in the
compared conditions. In lymphomas, only the dominant clone(s) are relevant, as
the rest of the clones in each sample represent other B-cells present in the tis-
sue, which are not related to the malignancy. Thus, MALT-L and DLBCL are not
included in the calculation of similarity measures because the dominant clones
in these conditions cannot be compared to the full repertoire samples from other
conditions.
In the case of GNHP, the DH3 and DH6 families were found to
be preferred, as combinations of V6D3J6 and V6D6J6 were used
significantly more than expected (Table 3; Figure 2B). Other over-
expressed DH genes were used in less prominent combinations in
the observed repertoire. Other combinations used in GNHP and
GHP, such as VH3-7, VH3-23, and VH3-30 – all with JH4 – used
several DH genes from different DH families.
Gastritis without H. pylori background and GHP pre-
sented almost identical gene usage patterns, having VH5-
51/JH4 and VH6-1/JH6 as the two most frequent combinations
(Figures 2A,B). VH5-51 and VH6-1 have been shown to often
participate in earlier stages of repertoire development via positive
selection by auto-antigens (Table 2). These two combinations also
appeared in our control lymph node (CLN) samples (Figure 2C),
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Table 2 | A summary of frequent combinations and genes in conditions from our study and from other studies.
Gene or combination Common in our study in Appeared in the literature in relation to
VH1-2 MALT-La Self-reactive antibodies, Bahler et al. (44)
Chronic lymphocytic leukemia (B-CLL), primary central nervous system lymphomas,
and splenic marginal zone lymphomas, Walsh and Rosenquist (45)
VH1-3 GNHP, GHP B-CLL, Fais et al. (46)
VH1-18 GNHP, GHP, DLBCL B-CLL, Fais et al. (46)
Autoreactive gene, Yamashita et al. (47)
BM-DLBCL, gastric MALT-Ls, Bende et al. (48)
VH1-8 DLBCL B-CLL, Pimentel et al. (49)
VH1-69 MALT-La, DLBCL Rheumatoid factor, Bende et al. (48), Matsuda et al. (50)
Gastric MALT-Ls, Bende et al. (48)
B-CLL, Fais et al. (46), Pimentel et al. (49), Johnson et al. (51)
VH2-26/JH5 MALT-La FL, Bayerl et al. (52)
VH2-26 MALT-La B-CLL, Pimentel et al. (49)
Hairy cell leukemia, Hashimoto et al. (53)
VH3-7 MALT-L Dominant, DLBCL Rheumatoid factor, Bende et al. (48), Matsuda et al. (50)
Rheumatoid arthritis, Nakamura-Kikuoka et al. (54)
Sjögren syndrome, Bahler and Swerdlow (55)
B-CLL, Fais et al. (46)
BM-DLBCL, Yamashita et al. (47)
Gastric MALT-Ls, Bende et al. (48)
VH3-23 DLBCL IgM+ B-cells, Brezinschek et al. (56)
Naïve B-cells, Wu et al. (57)
Anti-DNA auto-antibodies, Matsuda et al. (50)
Hepatitis C virus-related mixed cryoglobulinemia, Perotti et al. (58)
Unmutated VH3-23 in transformation from B-CLL into DLBCL, Mao et al. (59)
Gastric MALT lymphomagenesis, Sakuma et al. (60), Lenze et al. (61), Alpen et al. (62),
Siakantaris et al. (63)
BM-DLBCL, Yamashita et al. (47)
B-CLL, Pimentel et al. (49)
VH3-30 DLBCL Rheumatoid factor, Bende et al. (48), Matsuda et al. (50)
Gastric MALT lymphomagenesis, Sakuma et al. (60), Lenze et al. (61), Alpen et al. (62),
Siakantaris et al. (63)
B-CLL, Pimentel et al. (49)
VH3-30/JH4 DLBCL FL, Bayerl et al. (52)
VH5-51 and VH6-1 CLN, GNHP, GHP, and DLBCL Auto-antigens, Matsuda et al. (50)
Dominant
The dominant segments are marked with “Dominant” indication. The dominant segments/combinations are those that appeared in the largest clone in each sample.
aRepresents frequent genes or combinations in the repertoire of unique sequences.
so they probably have no specific connection to gastritis or H.
pylori response. However, the VH1-18/JH4 combination was more
frequently used in GNHP than in GHP, and was not prominently
observed in other conditions. As VH1-18 is an autoreactive gene
and was found in several gastric MALT-Ls (Table 2), VH1-18
may be involved in the development of gastritis regardless of the
presence of H. pylori.
One combination was over-expressed in both types of gastritis
(V3D0J5), and two combinations (V6D3J6 and V6D6J6, Table 3)
were over-expressed in GNHP (as dominant clones) and in DLBCL
samples (not the dominant clones). As can be seen in Figures 2B,C
and 3A, many sequences used the V6–J6 combination in GNHP
and DLBCL, but also in the controls. Thus, this combination is
very frequent in immune responses, and cannot be ascribed to a
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Table 3 | VDJ combinations that were over-expressed in each
conditiona.
Condition Combination p-Value Mean differenceb
GNHP V2D1J6 0.009 3.57
V3D5J4 0.002 4.38
V3D0J5 0.001 7.84
V6D6J6 0.035 3.84
V6D3J6 0.042 3.60
GHP V3D0J5 0.035 10.44
V5D3J2 0.015 3.26
DLBCL V1D1J6 0.011 1.30
Dominantc
V1D4J3 0.000 4.94
V4D6J4 0.046 2.70
V5D1J4 0.001 1.80
Dominantd
V5D7J4 0.036 2.20
V6D6J6 0.000 3.47
V6D3J6 0.003 3.50
aThere were no VDJ combinations that where over-expressed in MALT-L samples,
thus MALT-L does not appear in the table.
bRepresents the value of log2(observed/expected).
cThis combination was found in DLBCL samples number 1, 2, 3 (sample numbers
according toTable S1 in Supplementary Material).The dominant combinations are
those that appeared in the largest clone in each sample.
dThis combination was found in DLBCL sample number 5.
specific condition. However, the combination V3D0J5 may repre-
sent an antibody that is effective in the gastric environment, related
to inflammatory processes, or participates in both.
To conclude, both types of gastritis presented similar reper-
toires and diversity properties, in contrast to our expectation.
GASTRIC MALT-L EXHIBITED UNIQUE V(D)J COMBINATIONS
Several studies have demonstrated that gastric MALT-L is often
associated with a bacterial infection, most commonly by H. pylori;
another association has been revealed between gastritis and gas-
tric MALT-L (11–13). Therefore, we expected to find similar
V(D)J combinations when comparing the two conditions. Sur-
prisingly, the dominant MALT-L V(D)J combinations were very
different from those in GHP. While GHP showed an extensive
use of JH4 family genes and several common combinations, of
which the most frequent was VH5-51/JH4, in MALT-L dominant
clones were VH3-7/JH4, VH1-69/JH6, and VH1-2/JH1. VH3-7
is frequently found in rheumatoid factors and was selectively
expressed by patients with rheumatoid arthritis and Sjögren syn-
drome. Preferential use of these genes and combinations has
been reported in several types of lymphomas and leukemias
(Table 2).
Table S2 in Supplementary Material presents the combina-
tions that were over-expressed in one condition while under-
represented in the other. It can be seen (from the “Mean devi-
ation” column) that over-expressed combinations were almost
absolutely from either MALT-L or DLBCL samples (domi-
nant clones only). As DLBCL contained dominant combina-
tions that also appeared in other conditions, this supports the
observation of different dominant combinations in MALT-L
compared to those observed in other conditions. These com-
binations may relate to the malignancy, but this remains to
be explored.
We also compared the dominant clones in DLBCL and MALT-
L samples, as in some cases DLBCL appears in association with
MALT-L (18, 19). DLBCL is considered in these cases to result
from clonal transformation of large cells within the low-grade
lymphoma (64, 65). Hence, we expected to identify similar seg-
ment combinations on the dominant clones from the two con-
ditions. However, the dominant clones of MALT-L samples were
different from those of DLBCL (Figures 3A,B). As mentioned
above, the dominant clones in MALT-Ls were VH3-7/JH4, VH1-
69/JH6, and VH1-2/JH1, while in DLBCLs these combinations
were found, but were not the dominant clones. VH5-51/JH4 and
VH6-1/JH6 were frequent combinations in all conditions, except
in MALT-L, suggesting they may have some advantage in binding
common antigens. In terms of unique sequences, MALT-Ls pre-
sented completely different dominant combinations from DLBCL
(VH1-2/JH1, VH1-69/JH6, VH2-26/JH5, and VH3-7/JH4, data
not shown). Preferential use of these genes and combinations
has been reported in several types of lymphomas and leukemias
(Table 2). In addition, VH3-7/JH4, which was the most fre-
quent combination in MALT-L dominant clones, appeared in
all other conditions but with dramatically lower numbers. As
mentioned above, VH3-7 participates in the formation of auto-
antibodies and was found in several gastric MALT-Ls. Some
MALT-Ls were found to use VH genes previously associated with
auto-reactivity. This suggests that B-cells in MALT-L react with
self-antigens (66), different from those that arouse in GHP and
DLBCL responses.
MALT-L DOMINANT CLONES HAD LONGER DIVERSIFICATION HISTORY,
IN CONTRAST TO DLBCL CLONES
Lineage trees of the MALT-L dominant clones had significantly
longer trunks (T) and path lengths (PLmin), which are tree
length measures, than all other conditions (Figure 4; Figure
S1 in Supplementary Material). In addition, according to the
correlation of tree properties with the dynamic parameters of
the secondary B-cell response (67), longer trunks correlate with
a lower initial affinity, and longer paths also correlate with
a lower selection threshold. This suggests that diversification
history in MALT-L dominant clones was longer than that of
other conditions.
On the contrary, DLBCL dominant clones had significantly
shorter trunks and path lengths than those of GHP (and MALT-
L), and in general, the lowest tree length measures. Dominant
clones of DLBCL presented similar tree length measures to those
of CLN (Figure 4; Figure S1 in Supplementary Material). This is
in line with the above-described observation of similarity between
DLBCL and CLN. The shorter lengths observed in DLBCL, which
correlate with high initial affinity and selection threshold, may
indicate a shorter diversification process compared to MALT-L and
GHP (21). A possible explanation for this is that, because MALT-L
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FIGURE 3 | Average percentages of clones in each VH–JH combination, in (A) DLBCL and (B) MALT-L samples.
is an indolent lymphoma and DLBCL is an aggressive lymphoma,
the latter usually has less time to diversify until it is discovered
and treated. Figures S2 and S3 in Supplementary Material show
representative examples for MALT-L and DLBCL dominant trees,
respectively.
The fact that MALT-L dominant clones had larger trunks, path
lengths, and distance from the root to any split node, thus prob-
ably lower initial affinity than DLBCL dominant clones, suggests
that DLBCL dominant clones started as responses to specific (yet-
unknown) antigens, with probably higher initial affinity than the
responses that initiated MALT-Ls. That is, high affinity and vigor-
ous response may be risk factors for aggressive lymphoma devel-
opment. In terms of selection, these results show that selection
thresholds in MALT-L dominant clones were the lowest among all
other conditions. Low selection pressure may simply be the result
of abundance of antigen, and this may indeed be the case in gastric
MALT-Ls.
Dominant clones from the two types of gastritis presented sim-
ilar tree length measures, which correlate with the observed similar
repertoires.
DISCUSSION
In this study, we investigated the relationships between four
related conditions of the stomach: gastritis positive or negative
for H. pylori, gastric MALT-L, and gastric DLBCL. As previous
studies showed, these conditions sometimes appear successively,
as prolonged stimulation during chronic gastritis may result in
the development of gastric MALT-L, which in some cases fur-
ther transforms into DLBCL. We examined the clonal reper-
toires of the IgH variable region genes (or in the case of lym-
phomas, the dominant clones, which are defined as the largest
clone in each sample) and the lineage tree characteristics in each
condition, in order to find similarities or differences between
these conditions.
Both types of gastritis presented similar IgH variable region
gene repertoires and lineage tree characteristics, in contrast to our
pre-study assumptions. However, although the GNHP biopsies
were negative for H. pylori, it could be present in the tissue in
undetectable amounts, and thus affect the repertoire of the B-
cells in its surroundings. Moreover, both types of gastritis used
the VH1-18 gene, which may be involved in the development of
gastritis regardless of the presence of H. pylori; this remains to
be elucidated, as this was not the dominant combination in both
type of gastritis. We expected the repertoire in GHP to be less
diverse than that of GNHP due to the response to the bacterium,
which is expected to elicit only specific clones. In contrast to our
expectations, GHP samples showed at least as diverse repertoires
as GNHP (Figures 1 and 2A,B). An explanation for a high diver-
sity in GHP might be the phase variation of H. pylori, which is the
generation of intra-strain diversity that is important for bacterial
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FIGURE 4 | Lineage tree analysis – comparison between dominant
clones from the three MALT-L samples (24 trees) and the five DLBCL
samples (47 trees). There was more than one tree per sample, as we
included all clones with the same VH and JH genes (but different alleles) in
the dominant clone in each sample, because they might be related to the
dominant clone and falsely attributed to other alleles. Significant differences
were found in trunk length (T) and minimal path length (PLmin). An asterisk
(*) represents p-value <0.01; two asterisks (**) represents p-value <0.005.
niche adaptation (68), and could cause variability not only in the
bacterial strains but also in the responding antibody repertoire.
Hussell et al. (69, 70) showed that the extreme variability of H.
pylori strains led to diverse T cell responses. Moreover, they showed
that B-cells did not respond to H. pylori themselves, but required
contact-dependent help from H. pylori-specific T cells, and their
Ig genes responded to auto-antigens, similar to our observations.
Alternatively, the repertoires in the biopsies – even GHP biopsies –
may reflect immune responses to a variety of pathogens, including
but not limited to H. pylori.
Although in many cases DLBCL is associated with MALT-L, the
two types of lymphomas presented different dominant clone com-
binations and lineage tree characteristics. DLBCL may develop
after prolonged stimulation during gastritis, derive from a low-
grade malignant clone, or it can initiate de novo, depending on
the mutations in each clone. In this study, as MALT-L and DLBCL
presented different dominant clone combinations, in contrast to
our expectations; we speculate that in these cases DLBCL may have
initiated de novo. MALT-L samples presented different lineage tree
characteristics from those of all other conditions, although we
expected MALT-L to resemble GHP. In fact, we identified pref-
erential use of the autoreactive gene VH3-7 in MALT-L samples.
VH3-7 was one of the common VH genes in GHP (but not the
dominant clone). These findings suggest that gastric MALT-L is
derived from highly restricted B-cell subsets probably resulting
from specific antigenic stimulation, such as with H. pylori (15).
It is possible that B-cells in MALT-L react with self-antigens (66),
however, the role of self-antigens in the development of the malig-
nancy has yet to be examined. Moreover, lineage tree drawings
demonstrated longer trunks and path lengths in MALT-L domi-
nant clones, compared with all other conditions. These differences
in tree characteristics correlate with lower initial affinity and lower
selection threshold, respectively. Low selection pressure may sim-
ply be the result of abundance of antigen, and this may indeed be
the case in gastric MALT-L. The above may indicate that MALT-L
has undergone a longer mutational history than other conditions.
On the contrary, the shorter lengths observed in DLBCL dominant
clones may be a result of shorter diversification and responses to
specific (yet-unknown) antigens, with higher initial affinity com-
pared to MALT-L and the two types of gastritis (21). The latter
may be risk factors for aggressive lymphoma development.
We observed some similar VH–JH combinations in all condi-
tions, together with over-expressed and preferred combinations
unique to gastritis, MALT-L, and DLBCL samples. These combi-
nations should be investigated in order to further understand their
role in the development of each condition. For example, the rela-
tively extensive use of combinations, which were previously found
in other malignancies, in DLBCL samples in this study reinforces
the notion that some DLBCL clones had developed from MALT-L
clones. Moreover, the fact that the dominant combinations were
identical in all conditions except in MALT-L (and that MALT-L did
not contain this combination at all) is interesting and should be
further investigated. We also identified frequent VH genes in GHP
repertoires and in the dominant clones in MALT-L samples, which
were also found in autoimmune diseases. It was previously shown
that some autoreactive B and T cells are activated during H. pylori
infection (71). The connection between the appearances of these
VH genes in GHP and MALT-L samples from our study and in
autoimmune diseases remains to be explored. There was no promi-
nent trend toward any V, D, or J gene family in the over-expressed
combinations in each of the conditions. However, combinations
that were over-expressed in lymphoma dominant clones compared
to other conditions had a clear preference toward the use of VH2,
JH1 in MALT-L and VH1, JH2 in DLBCL. The role of these
combinations and gene families in lymphomas is still unknown.
It should be noted that, because we studied formalin-fixed
paraffin-embedded archival biopsies, we had access to only a lim-
ited number of biopsies, and limited amounts of DNA, as DNA
in the preserved biopsies is often denatured (72). More samples in
more conditions will have to be studied in order to give a clearer
picture of the roles of specific V(D)J genes and combinations in
inflammation and malignancies. Moreover, the similarity between
conditions is also affected by the limited number of samples in
each condition. This may cause the similarity calculations to be
biased toward random features of the samples that may char-
acterize a certain condition, and thus affect the interpretations.
However, the similarity between samples within each condition
was not very large, so it is unlikely that some random feature is
common to all samples of the same condition. Coincident with
obtaining more samples, we intend to use the Illumina high-
throughput sequencing (HTS) in future studies, in order to avoid
the 454 sequencing artifacts, which resulted in discarding many
sequences (73). A possible argument could be raised regarding the
exclusion of duplicate sequences from our analysis. As mentioned
in the Section “Materials and Methods,” duplicate sequences may
stem from the PCR amplification, and may cause misidentification
of dominant clones. Although we stringently defined duplicate
sequences as those that had the exact nucleotide composition
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and equal lengths, most of the sequences differed not only by
their lengths, but also in the mutations they include. Table S5
in Supplementary Material summarizes the distributions of the
number of sequences in the tree-nodes in the dominant and sec-
ond dominant clones in lymphoma samples. As can be seen from
Table S5 in Supplementary Material, most of the nodes contained
only one sequence, implying that most of the sequences differed
not only in their lengths, but also in the mutations they include.
There were, however, several nodes that contained more than one
sequence. This does not necessarily indicate that those sequences
are duplicates, as the clone-tree is built according to the aligned
sub-sequences that are shared between all sequences in the clone.
This means that sequences included in a specific node could differ
in their ends, and not necessarily be duplicates.
All conditions in this study presented similar mutation rates
and the same SHM targeting motifs. Replacement and silent
mutation analysis revealed a strong selection against replacement
mutations in the CDR regions of all conditions. This may indicate
that most of the examined IgH variable region gene sequences rep-
resented B-cell receptors (BCRs) that were already highly specific
to their antigens and thus selection operated against replacement
mutations in their CDR regions, which are responsible for antigen
binding. These results are also consistent with previous work on
lymphomas from our lab (30).
In this study, we used the Morisita similarity index in order
to measure similarity between conditions (as mentioned in the
Section“Materials and Methods”). Similarity measures were calcu-
lated between all clones in all samples in the compared conditions.
In lymphomas, only the dominant clone(s) are relevant, as the rest
of the clones in each sample represent other B-cells that are also
present in the tissue, but are not related to the malignancy. Thus,
the MALT-L and DLBCL conditions were not included in calcu-
lation of similarity measures exactly because the dominant clones
in these conditions cannot be compared to the whole other sam-
ples in other conditions. In addition, Morisita similarity index is
of order 2, which emphasizes large clones. This affects the similar-
ity results. However, we are interested in the larger clones in each
condition as they probably represent the dominant responses.
In summary, we showed that gastritis positive or negative for H.
pylori presented very similar IgH variable region gene repertoires.
This suggests that the diverse stomach repertories do not change
much due to the presence of the bacteria, and moreover, GHP
does not become oligoclonal (or at least with narrower repertoire)
due to H. pylori. MALT-L, however, presented different and unique
dominant clone gene combinations, which can result from specific
antigenic stimulation. As was mentioned in the Section“Introduc-
tion,” several studies showed that H. pylori causes gastritis, and
suggested that prolonged gastritis can lead to MALT-L, and that
prolonged MALT-L can develop into DLBCL. This flow and gradu-
ation of diseases led us to the assumption that the repertoires (VDJ
combinations) in these conditions would be similar, because these
conditions were initiated by the bacteria, and several clones got
out of control to progress into lymphoma. Moreover, the diversity
in these conditions was expected to be narrower than that in CLN,
and to be progressively lower as the conditions proceed toward the
aggressive lymphoma. However, the results differed from what we
expected. In addition, some combinations did appear in several
conditions, but not in MALT-L, and the DLBCL dominant clones
also appear in other conditions (so they were not unique to the
cancer). We speculate that the transformation into MALT-L, after
the prolonged stimulation by the chronic GHP, amplified specific
combination(s) that were also found in GHP but in a lower fre-
quency (such as VH3-7). The two types of lymphomas differed
in their dominant clone gene combinations and lineage tree char-
acteristics, suggesting differences in the abundance of antigens, if
not in their nature, which remain to be explored.
MATERIALS AND METHODS
HISTOPATHOLOGICAL SPECIMENS
Five gastric DLBCL biopsies, 3 gastric MALT-L biopsies, 10 chronic
gastritis biopsies (3 with H. pylori background and 7 that were neg-
ative for H. pylori), and 19 reactive lymph node biopsies (which
served as controls), each from a different patient, were selected
from the pathology department archives in the Sheba Medical
Center (Table S1 in Supplementary Material). Tissue biopsies
were taken during resection procedures and were used in this
study in accordance with institutional Helsinki committee guide-
lines and approval. Histochemical stains, by Hematoxylin-Eosin
(H&E) and Giemsa, were performed for histological evaluation
and H. pylori identification. For diagnosis of lymphoproliferative
disease and characterization of lymphocyte populations, immuno-
histochemical stains (e.g., CD20, CD3, CD23, CD21, cyclin-D1,
Ki67, and IgD) were also performed. All cases were revised by two
independent pathologists to confirm the diagnosis.
DNA EXTRACTION
Paraffin-embedded blocks were cut using a microtome to get
extremely thin slices of tissues (sections). Each of the biopsies was
consecutively cut to yield 10–20 sections of 4µ each, depending
on tissue size. All sections from each biopsy were inserted into an
eppendorf tube with 200µl water (Sigma) and were heated in 90°C
until the paraffin was melted. After the tubes were centrifuged at
full speed (14000 rpm) for 1 min, a paraffin ring was created and
could easily be removed from each of the tubes. Water was drawn
from the tubes while tissues remained in the tubes. Extraction of
DNA was then performed using the QIAamp DNA Mini Kit (or
the QIAamp DNA Micro Kit for very small samples) according to
the QIAGEN protocol.
In some cases, a micro-dissection was needed. First, H&E
stained thin sections were reviewed by a pathologist, and areas of
interest were outlined. The tissues were cut from 5 to 10 sections
that were placed onto five slides per tissue. The slides were heated
in 90°C for 15 min. Next, the slides were hydrated (5 min soak-
ing in Xylene, brief immersion in Ethanol 100, 96, and 70% in
this order). The slides were then placed to dry. According to the
outlined stained slides of each tissue, the hydrated slides were
scratched with buffer ATL (QIAamp DNA Mini Kit, QIAGEN) and
sample scrapings were picked up into eppendorf tubes. Extraction
of DNA was then performed using the QIAamp DNA Mini Kit (or
the QIAamp DNA Micro Kit for very small samples) according to
the QIAGEN protocol.
PCR AMPLIFICATION AND HIGH-THROUGHPUT SEQUENCING
For each sample taken from each biopsy, semi-nested PCR was per-
formed using the same forward primers for the two PCR rounds
and two different reverse primers as described below.
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Forward primers from FR2 region:
VH1: 5′-TGCGMCAGGCCCCYGGACAAR-3′,
VH2: 5′-ARGRAAGGCCCTGGAGTGG-3′,
VH3: 5′-CCAGGCTCCAGGSAAG-3′,
VH4: 5′-MGGGAAGGGRCTGGAGTGG-3′,
VH5: 5′-GAAAGGCCTGGAGTGGATGGG-3′,
VH6: 5′-TTGAGTGGCTGGGRAGGAC-3′.
Reverse primers:
First round – JH1R: 5′-TGAGGAGACGGTGACCAGGGT-3′,
Second round – JH2R: 5′-TGACCRKGGTHCCYTGGCCC-3′.
There is no specific primer for VH7 gene family in the FR2
region, as the VH7 primer in this region is very similar to that of
VH1, thus, it amplifies the VH1 family and creates a very strong
VH1 bias.
The primers were augmented for HTS experiments by the addi-
tion of 5′ sequencing adapter elements and 10-nucleotide unique
sample molecular identification (MID) tags according to the 454
FLX Titanium chemistry protocol (Roche) (74). Proofreading Taq
DNA polymerase (ABgene) was used in PCR reactions according
to the manufacturer’s protocol. PCR reaction was performed on
a sample of 50 ng DNA from each sample, with slight changes
according to calibration (because DNA was taken from different
tissues, and each tissue can differ in the percentages of lympho-
cytes). PCR products were separated on a 2% agarose gel stained
by ethidium bromide. Clear bands were cut from the gel and DNA
was extracted using the MinElute Gel Extraction kit (QIAGEN),
according to the manufacturer’s protocol. Sequencing of small
samples of the PCR products by the classic Sanger method (after
cloning to pGEM – T-easy vector) was performed in order to
make sure they are Ig gene amplifications and the sequences of
the primers and the tags are intact. DNA concentration of PCR
products from each sample were determined by PicoGreen dye
and fluorospectrometer (Nanodrop). According to these results,
a mixture containing 109 molecules of PCR products from each
sample was prepared and sent to sequencing. HTS was performed
using the 454 GS FLX Titanium platform by DYN Diagnostics Ltd.,
the sole representative in Israel of Roche Diagnostics. Raw data files
containing a total of ~120,000 reads were received when the HTS
was completed. Raw data files can be downloaded from the SRA
database, accession number PRJNA206548 (Runs: SRR873440,
SRR873441, SRR873442).
HTS RAW DATA PRE-PROCESSING
To process the 454 raw data, we used our program Ig-HTS-
cleaner (73). Ig-HTS-cleaner discards artifact sequences, assigns
the sequences to samples according to their MID tags, identifies
primers, and discards sequences much shorter or longer than the
expected length of an Ig variable region gene, or sequences with
average quality scores below a defined threshold. Parameters used
in the Ig-HTS-Cleaner run were as follows. Average quality score
threshold of 20, a maximum of 2 allowed mismatches in the primer
search, 75% of the primer’s length to search, and a range of 25 bases
at the ends of the read for the MID and primers search (Table S3
in Supplementary Material).
Next, we discarded duplicate sequences, which are completely
identical sequences, from each sample. We cannot exclude the
possibility that duplicate sequences are a result of the PCR amplifi-
cation; hence the existence of many identical sequences in a sample
does not necessarily indicate that the sequence is found in the
original biopsy in the same frequency.
Afterward, we used our program Ig-Indel-Identifier (Ig Inser-
tion – Deletion Identifier) (73), in order to identify legitimate
and artifact insertions and/or deletions (indels) in the sequences.
Parameters used in the Ig-Indel-Identifier run were as follows.
HPT length was set to 2, quality score threshold (for suspected
point mutations) of 25, and the number of sequences in the same
clone containing the same indel was set to 1 (Table S4 in Sup-
plementary Material). Table 4 presents the numbers of unique
sequences from each condition after discarding sequences with
suspected indels. These were the final numbers of sequences that
were analyzed.
GERMLINE VDJ SEGMENT IDENTIFICATION AND ASSIGNMENT INTO
CLONES
Clonally related sequences were identified by identical V(D)J seg-
ments and by highly homologous sequences of the CDR3 of their
Ig genes. For gene segment identification, we used SoDA (75). We
computationally grouped the sequences into clones based only on
their V, D, and J segments. We aligned clonally related sequences
using ClustalW2 (76), in order to confirm that the CDR3 in the
clonally related sequences were highly homologous. If not, we sep-
arated the sequences into clonally related groups according to the
different CDR3 sequences.
REPERTOIRE ANALYSIS
We enumerated the clones based on V(D)J combinations. Results
are presented as the average sample percentages of clones of
each VH–JH combination, across all samples within the same
group. Using the percentages normalizes for different numbers
of sequences and/or clones, due to sampling of different numbers
of B-cells or obtaining different DNA quantities in each case.
In order to examine the relationships between the VDJ com-
binations used in each repertoire, we needed to compare the
observed repertoires to repertoires predicted under some model,
for example, under the assumption that the expression of each
gene in each VDJ combination (e.g., V1D1J1) is independent
of that of other genes. Immunologists call this assumption “the
product rule” (77). Deviations from this assumption can thus
point at interdependencies between the V, D, and J genes. We
decided to look only at the gene family level, as higher reso-
lution (genes, alleles) would give extremely large numbers of
possible combinations, far from the number of combinations
observed and therefore the frequencies of each expected combi-
nation at the gene or allele level would be close to zero. Thus,
each observed gene combination would be significantly differ-
ent from the expected. Using only families of the VDJ segments
would solve this problem. For each sample, we counted the num-
ber of unique sequences that used each V, D, or J family. We then
calculated the frequency of each V/D/J family as the number of
unique sequences using this family divided by the total number
of unique sequences in the sample. We then created all possible
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Table 4 | Number of unique sequencesa, without suspected indelsb, from each condition.
CLN GNHP GHP MALT-L DLBCL Total
Number of patients (samples) 19 7 3 3 5 37
Number of unique sequences 23,308 4,676 3,373 3,851 4,389 39,597
Range of sequencesc 384–3,353 75–1,105 513–1,406 838–1,854 267–1,601
Dominant clone sizesd 360 (249) 162 (49)
461 (399) 325 (257)
408 (321) 58 (42)
78 (47)
418 (193)
aUnique sequence: a sequence that differs from all other sequences due to one or more insertion(s), deletion(s), or point mutation(s).
bAfter sequences with suspected indels were discarded.
cThe lowest-to-highest numbers of unique sequences without suspected indels in each sample from each condition.
dThe number of unique sequences in the dominant clone, and the number of the second dominant clone (in parentheses), in the lymphoma samples. Each couple of
numbers represents one-sample.
combinations that can be made using the observed VDJ fami-
lies, and defined their expected frequencies as the product of the
V/D/J family frequencies calculated in the previous step. Next,
we calculated the actual frequencies of the observed combina-
tions (number of unique sequences in each observed combination
divided by the total number of unique sequences). There was no
point in creating combinations with families that did not appear
in the sample, as there was no meaning of calculating frequencies
of non-existing combinations.
In order to know whether a combination was expressed
more or less than expected, we calculated the expression:
log2(observed/expected). If a specific combination was over-
expressed compared to the expected frequency, the ratio inside
the logarithm would be larger than 1, as the observed frequency
would be larger than the expected,and thus the logarithm would be
positive. On the other hand, if a specific combination was under-
expressed compared to the expected frequency, the ratio inside the
logarithm would be smaller than 1, and thus the logarithm will
be negative. Combinations that were not observed at all received
the value (−∞), because the expression inside the logarithm was
zero. This step was repeated for each sample. It is important to
note that most of the combinations (>80%) were observed in a
significantly different frequency than expected. Out of these com-
binations, 99% were under-represented (because the number of
combinations observed is smaller than the potential number), and
only 1% of the combinations were over-expressed compared to
the expected frequency, and any such case of over-expression was
thus particularly noticeable.
The final step was to unite all combinations from all samples as
follows: we created a matrix, where rows represented samples and
columns represented VDJ combinations. For each combination
and for each sample, we inserted the logarithm that was calcu-
lated as above. If a sample did not have a specific combination, the
cell would be left unfilled. The full matrix was used to carry out
the statistical tests. In order to examine whether some combina-
tions tend to appear more or less than expected, we carried out a
one-sample t -test on each of the conditions. In order to examine
differences in combination usage between conditions, we carried
out a two-sample ANOVA test.
In order to graphically present repertoires, we only plotted V–J
repertoires, not showing the DH segments used in each VH–JH
combination. There are several ways of presenting also the DH
genes used in the repertoires (78, 79). However, as mentioned
above, DH segments are sometimes misidentified, so we preferred
to focus on V and J segments.
DIVERSITY ANALYSIS
Clones in samples can be regarded as species in habitats
In the case of lymphocyte clonal repertoire samples (e.g., those
obtained from tissue biopsies), we treat each sample as a sam-
ple from a habitat, in which the “species” are the BCR or TCR
clones found in the sample. Each of the clones may be composed
of a number of different sequences. In TCR clones, all sequences
are identical, but in BCR clones sequences from the same clone
may be different due to SHM, and one may choose to use only
unique sequences found, or all sequences including multiplicate
ones. The latter choice depends on whether identical sequences
coming from different cells can be identified as such, or cannot be
distinguished from sequence duplications caused by PCR amplifi-
cation. If the former is true (as when using random barcoding in
the PCR primers), then the number of sequences that come from
different cells is known, and can be used to estimate diversity. If
not, then TCR diversity cannot be estimated, and BCR diversity
can only be estimated based on the numbers of unique sequences
and thus would usually only gives a minimum estimate of the total
diversity, as we have done in this study.
Diversity indices
In order to quantify the diversity of clonal repertoires (such as
antibody/BCR or TCR gene repertoires) in each experimental or
clinical condition, and later to be able to compare between two
or more conditions, we used diversity indices (such as the Species
Richness, the Shannon entropy, or the Simpson concentration,
which are indices of order 0, 1, and 2, respectively) (80). These
indices take into account the number of species and (in indices
of order >0) the frequency of members of a species (in our case,
sequences) of each species (in our case, clone) in each habitat sam-
ple. In indices of order 0, diversity is defined simply as number of
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species (in our case, lymphocyte clones) in a sample. In order 1
indices, clone size (or frequency) is taken into account, as in the
Shannon entropy when diversity is the sum of
[− p∗i ln (pi)] , where
i represents a species or clone and pi represents its size (the number
of members/sequences, see below). Order 2 indices attribute more
weight to large clones, as in the Simpson concentration, which is
the sum of p2i . In our studies, we used both order 1 and 2 diversity
indices, i.e., the Shannon entropy and the Simpson concentration.
Diversity measures
From the sample diversity indices, we have calculated the alpha,
beta, and gamma diversity measures for each condition (80). The
alpha diversity measure represents the average sample diversity in
each condition/population. In order to calculate alpha, we calcu-
late the alpha diversity of each sample, and then average over all
samples from the same condition. The gamma diversity measure
represents the “global” repertoire diversity across all samples stud-
ied in each condition/population. It is calculated as the diversity
of the pool containing all the sequences from all the samples from
the same condition/population.
Finally, the beta diversity measure, which represents the diver-
sity component resulting from the variability between samples, is
derived from the alpha and gamma measures using the method
of Jost et al. (80). The beta diversity measure is calculated as
the gamma diversity of each condition/population divided by the
alpha diversity (average of the diversities of individual samples).
In order to allow an intuitive comparison between the diversities
of each of the groups, all the diversity measures can be expressed as
their number equivalents (80), which reflect the number of equally
sized clones needed to produce the given value of the diversity
index.
Estimating the full repertoire from the sample
Considering the large number of sequences that were observed
only once in each sample, it is likely that many rare clones in an
individual’s original full repertoire were not detected. To account
for the presence of unobserved“species”(clones), all diversity mea-
sures can be estimated for whole repertoires (rather than calculated
for the sample) using the method described by Chao and Shen (81),
which is based on a non-parametric estimation of diversity indices
where there are undetected species. Chao and Shen’s approach uti-
lizes the concept of sample coverage to adjust the diversity indices
for clones that escaped sampling. The sample coverage is estimated
from the proportion of species/sequences that are observed only
once within a sample.
In our Ig gene repertoire studies, the abundance data (num-
bers of unique sequences) of antibody clones in each sample were
used to estimate the mean, standard error, and 95% CI of the total
number of unique sequences in clones within each sample. This
was done using SPADE©, a program designed for diversity calcu-
lations (81). The alpha diversity for each sample, and the gamma
diversities for combined samples in each condition, were then cal-
culated from the order 1 or 2 diversity indices of the estimated
total repertoires, also using SPADE©(81). In principle, beta is cal-
culated as the average alpha of all samples in the condition divided
by the gamma of the condition, as explained above. In order to
compare between conditions, however, we needed to calculate CI
for beta. This was done by calculating beta index per sample (alpha
of the sample divided by the gamma of the condition) and then
calculating the CI for each condition (Figure 5).
SIMILARITY ANALYSIS
Another method we used to compare between conditions is the
Morisita similarity index (82). SPADE©(81) was used to calculate
a similarity matrix, in which we measured each individual reper-
toire’s similarity to all other individual repertoires. The average
of similarity indices of individuals in a given group to those in
another group represents the similarity index for the comparison
between the two groups. A value close to 1 represents high sim-
ilarity between two groups, and a value close to 0 represents low
similarity.
The highest values of the Morisita similarity indices represent-
ing the highest similarity were rather low and relatively far from
1, indicating the sensitivity of this method. However, they were
consistent with observed repertoire diversities.
Ig LINEAGE TREE ANALYSES
Clonally related Ig gene sequences from each sample were used to
create mutational lineage trees using our program IgTree©(83), as
described in previous work (29, 30). All trees were measured using
our program MTree©, quantifying the graphical properties of the
trees (84, 85). A thorough statistical analysis has concluded that
seven specific tree characteristics possess the highest correlation
values with the biological parameters and are hence most infor-
mative (67). As described there, these properties are the minimum
root to leaf path length, the average distance from a leaf to the first
split node/fork, the average outgoing degree, that is the average
number of branches coming out of any node, the root’s outgoing
FIGURE 5 | Illustration of the calculation of repertoire diversity. First,
the diversity indices (Shannon entropy, Simpson concentration index, etc.)
are calculated for the pool of samples in each condition and also for each
sample separately (samples are denoted by X 1, . . ., X n. Diversity indices
are denoted by D (sample) or D (pool)). Next, the distribution measures (α,
β, γ) are calculated for each condition using the samples. γ is the pool
diversity, α is the mean sample diversity, and β for each sample is γ divided
by D (sample). Finally, the CIs of the distribution measures are compared
between the populations/conditions.
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degree, minimum distance between adjacent split nodes/forks, the
length of the tree’s trunk and minimum distance from the root
to any split node/fork. The analysis in this study has thus focused
on these properties. Comparison between lineage tree character-
istics of different conditions was done using the non-parametric
Mann–Whitney U -test, as normal distributions (required by tests
such as Student’s t -test) could not be assumed. We used the FDR
correction (86) for multiple comparisons.
Replacement (R) and silent (S) mutation analysis methods
attempt to measure the extent of selection operating on the
diversifying clones. These methods compare the frequencies of
replacement mutations found in the frame-work and CDR regions
of mutated Ig gene sequences to their expected frequency, based
on codon usage of the germline sequence. We used the updated
focused binomial test by Hershberg et al. (87, 88). The numbers of
observed mutations were pooled for each data group by IgTree©,
and the new focused binomial formula (88) was calculated using
Microsoft Excel©. This measure was also performed for each sam-
ple separately, yielding the same results; however, when comparing
conditions, we chose to show the pooled analysis for simplicity.
Additional mutational analyses were carried out as described in
previous studies (27, 28, 30), however, no significant differences
between the conditions were found.
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